Back to search
FDAFDA · Food and drugs·Recall number D-1360-2020

Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61

Published July 8, 2020 · Recall initiated: June 12, 2020

Summary

FDA records drug Class II recall D-1360-2020, published July 8, 2020 and initiated June 12, 2020. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 1,906 Cartons; Lot: Lot T-02134, exp 09/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Harvard Drug Group
Distributor
Nationwide USA
Lot
Lot T-02134, exp 09/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Metformin Hydrochloride Extended-Release Tablets, USP, 500 mg, 100 Tablets (10 x 10) unit dose cartons, Rx only, Manufactured by: Apotex, Inc., Toronto, Ontario, Canada, Manufactured for: Apotex Corp. Weston, FL, Distributed by: Major Pharmaceuticals, Livonia, MI 48152 NDC 00904-5794-61 recalled?

Yes. FDA published recall D-1360-2020 on July 8, 2020. Reported hazard: CGMP Deviation: Potential presence of Nitrosodimethylamine (NDMA) Impurity above the established levels.

What should I do if I have this product?

Voluntary: Firm initiated · Letter